{
  "id": 3667094,
  "title": "Jazz Pharmaceuticals prices $1.1B exchangeable notes offering",
  "url": "https://urgent.news/2026/08/27/jazz-pharmaceuticals-prices-1-1b-exchangeable-notes-offering",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T04:36:35.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/jazz-pharmaceuticals-prices-11b-exchangeable-notes-offering-93CH-4878314"
  },
  "original_language": "en",
  "account": "Jazz Pharmaceuticals plc announced the pricing of $1.1 billion in exchangeable senior notes due in 2032, a size increase from the initial $1.0 billion offering. The notes, issued by Jazz Investments I Limited, grant initial purchasers the option to buy an additional $150 million within 13 days. Set to mature on September 15, 2032, the notes offer a semiannual interest rate of 1.875% starting March 15, 2027. The exchange rate is 2.8150 ordinary shares per $1,000 principal amount, with an initial price around $355.24 per share, marking a 42.5% premium compared to the previous Nasdaq sale. The issuer may redeem the notes on or after September 20, 2029, if the share price hits 130% of the exchange price for 20 consecutive trading days. Jazz estimates net proceeds of approximately $1.079 billion post-expenses, or $1.226 billion if all initial purchasers exercise their option. The funds will be used for general corporate purposes, including the repurchase of around $225 million of ordinary shares from note holders at $249.29 each, as part of the company's share repurchase program initiated in July 2024.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Jazz Pharmaceuticals Plans $1 Bln Notes Offering, Concurrent $225 Mln Share Buyback",
        "url": "https://urgent.news/2026/08/26/jazz-pharmaceuticals-plans-1-bln-notes-offering-concurrent-225-mln",
        "published": "2026-08-26T12:16:41.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}